Close Menu

NEW YORK (GenomeWeb) – New research suggests that recurrent mutations in the RB1 gene, which encodes the retinoblastoma protein, are associated with aggressive disease and decreased survival following anti-androgen hormone treatment in men with advanced prostate cancer.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.